IPA-3, 95%, 25mg

1-Isopropyl-1H-pyrazolo[3,4-b]pyridine-6-carboxylic acid, 50g

5-Chloropyrazolo[1,5-a]pyrimidin-7(1H)-one, 95.0%, 100mg

DL-3-Hydroxybutyric Acid (contains Polymolecular esterification product)>80.0%(T)25g

(3-((Neopentyloxy)sulfonyl)phenyl)boronic acid, 95.0%, 100mg

2-(3-Nitrophenyl)-4-phenylthiazole, 1g

(2,3-Difluoro-4-nitrophenyl)methanol, 98%, 1g

5-Methylisophthalic Acid>98.0%(GC)(T)5g

N-(biphenyl-4-yl)-N-(4'-broMobiphenyl-4-yl)-9,9-diMethyl-9H-fluoren-2-aMine, 97%, 5g

Microliter syringe GASTIGHT® series 1000, 2.5 ml, 1002 TLL, 1 piece

6-Fluoro-2-methyl-4-chromanone, 97.0%, 250mg

2-Bromo-1-ethylpyridinium Tetrafluoroborate>98.0%(HPLC)(T)5g

2-METHYL-5-OXO-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER, 95.0%, 1g